We are live on ! Find out more
ETON icon

Eton Pharmaceutcials
ETON

17 hedge funds and large institutions have $24.3M invested in Eton Pharmaceutcials in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

29% more capital invested

Capital invested by funds: $18.9M → $24.3M (+$5.4M)

21% more funds holding

Funds holding: 14 → 17 (+3)

18.66% more ownership

Funds ownership: 14.73% → 33.39% (+19%)

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
5
Increased
7
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$12.7M
2
AIC
AWM Investment Company
New York
+$2.92M
3
DC
Diametric Capital
Massachusetts
+$2.64M
4
PCM
Prelude Capital Management
New York
+$874K
5
Renaissance Technologies
Renaissance Technologies
New York
+$212K

Top Sellers

Rank Fund Capital Flow
1
CWM
Centric Wealth Management
Illinois
-$202K
2
First Trust Advisors
First Trust Advisors
Illinois
-$22.9K
3
Wells Fargo
Wells Fargo
California
-$17.1K
4
PMFA
Plante Moran Financial Advisors
Michigan
-$5.84K
5
BlackRock
BlackRock
New York
-$2.55K
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
1
Opaleye Management
Massachusetts
$14.9M +$12.7M +2,170,544 +148%
AIC
2
AWM Investment Company
New York
$4.17M +$2.92M +500,000 +97%
DC
3
Diametric Capital
Massachusetts
$1.85M +$2.64M +452,103 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.16M +$7K +1,200 +0.4%
PCM
5
Prelude Capital Management
New York
$1.14M +$874K +149,733 +117%
BlackRock
6
BlackRock
New York
$301K -$2.55K -437 -0.6%
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$268K +$6.02K +1,032 +2%
Renaissance Technologies
8
Renaissance Technologies
New York
$149K +$212K +36,283 New
Northern Trust
9
Northern Trust
Illinois
$88K – – –
First Trust Advisors
10
First Trust Advisors
Illinois
$83K -$22.9K -3,925 -16%
BBVA
11
Banco Bilbao Vizcaya Argentaria
Spain
$61K +$87.5K +15,000 New
UBS Group
12
UBS Group
Switzerland
$28K +$24.4K +4,181 +164%
Morgan Stanley
13
Morgan Stanley
New York
$24K +$3.91K +670 +13%
Victory Capital Management
14
Victory Capital Management
Texas
$20K +$28.4K +4,858 New
Wells Fargo
15
Wells Fargo
California
$12K -$17.1K -2,927 -49%
PMFA
16
Plante Moran Financial Advisors
Michigan
$4K -$5.84K -1,000 -50%
WIM
17
Westside Investment Management
California
$195 +$279K +47,750 New
CWM
18
Centric Wealth Management
Illinois
– -$202K -28,000 Closed

ETON Hedge Fund Activity: Q1 2020 in Review

17 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q1 2020, worth a combined $24.3M — up 29% from $18.9M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ETON positions and 2 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Opaleye Management, adding an estimated $12.7M. The largest seller was Centric Wealth Management, exiting entirely with an estimated $202K sold.

  • 17 institutional investors held Eton Pharmaceutcials (ETON) as of Q1 2020, up from 14 in Q4 2019.
  • Funds reported $24.3M of Eton Pharmaceutcials stock for Q1 2020, up 29% quarter-over-quarter.
  • 5 funds opened new Eton Pharmaceutcials positions in Q1 2020 and 2 closed out, a net change of +3 holders.
  • The largest Eton Pharmaceutcials buyer in Q1 2020 was Opaleye Management, an estimated $12.7M added.
  • The largest Eton Pharmaceutcials seller in Q1 2020 was Centric Wealth Management, an estimated $202K sold.

Based on aggregated 13F filings for Q1 2020.